Navigation Links
18 month Follow-up Data on Phase III Study of Pixantrone in Late Stage Relapsed or Refractory, Aggressive Non-Hodgkin's Lymphoma Continues to Demonstrate Significant Improvement in Complete Remission and Progression Free Survival Over Standard Chemotherap
Date:9/15/2009

ved two or more prior therapies and who were sensitive to treatment with anthracyclines. The trial was conducted at 130 sites in 17 countries. Patients were randomized to receive either pixantrone or another single-agent drug currently used for the treatment of this patient population and selected by the physician. The trial was designed to examine the complete remission (CR) or unconfirmed complete remission (uCR) rate, time to tumor progression, and overall survival. The study was conducted under a Special Protocol Assessment from the U.S. Food and Drug Administration (FDA) and pixantrone has received fast track designation for this indication.

About Pixantrone

Pixantrone (BBR 2778), is a novel topoisomerase II inhibitor with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines are the cornerstone therapeutic for the treatment of lymphoma, leukemia, and breast cancer. Although they are sufficiently effective to be used as first-line (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a lifetime limit of anthracycline doses and most patients who previously have been treated with an anthracycline are not able to receive further anthracycline treatment if their disease returns. It also can be administered through a peripheral vein rather than a central implanted catheter as required for other drugs in this class. Pixantrone has been granted fast track status designation.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
2. Ferring Pharmaceuticals Unveils Six-Month Efficacy Data for EUFLEXXA(R) for the Treatment of Osteoarthritis Knee Pain
3. Alimera Sciences Announces Presentation of Data From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study at ARVO 2009 Annual Meeting
4. MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up
5. Medgenics Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients
6. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
7. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
8. Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months
9. Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death
10. Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
11. 12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 6, 2015 Alexza Pharmaceuticals, Inc. (Nasdaq: ... ended March 31, 2015.  The net loss and the ... million and $13.0 million, respectively, compared to $10.7 million ... respectively.  At March 31, 2015, Alexza had consolidated cash, ... million. "We continue to focus on ways ...
(Date:5/6/2015)... Lannett Company, Inc. (NYSE: LCI ) today reported ... March 31, 2015.  For the fiscal ... million from $80.0 million in last year,s third quarter.  ... of net sales, from $56.1 million, or 70% of ... $9.2 million from $10.6 million for the fiscal 2014 ...
(Date:5/6/2015)... /CNW/ - Celebrities, bloggers and influencers across North America ... important message that melanoma prevention begins with parents-encouraging everyone to ... Hilary Duff , and parenting author Alyson Schafer ... networks on Monday to share this poignant video message: ... David Cornfield Melanoma Fund (DCMF)-producers of the viral ...
Breaking Medicine Technology:Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 2Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 3Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 4Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 5Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 6Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 7Lannett Reports Strong Fiscal 2015 Third-quarter Financial Results 8Celebrities Tweet Their Support of Melanoma Awareness Month and #newfamilyrule 2
... 2011 BioParadox, Inc., a regenerative medicine company ... announced that Michael Kleine, President & Chief Executive ... Board of Directors. "Mr. Kleine,s impressive ... commercialization of our novel biologic cardiovascular therapies.  We ...
... Texas, Dec 12, 2011   e-MDs , the provider ... record (EHR), announced that providers at Southwest Family ... the first physicians in the state of Nebraska to ... funds from the Medicare EHR Incentive Program for their ...
Cached Medicine Technology:Regenerative Medicine Company BioParadox adds Healthcare and Medical Device Expert, Michael Kleine, to its Board of Directors 2e-MDs Physicians are Among Nebraska's First to Attest for Meaningful Use 2e-MDs Physicians are Among Nebraska's First to Attest for Meaningful Use 3
(Date:5/6/2015)... Springs, Texas (PRWEB) May 06, 2015 ... stages of the HIMSS EMR Adoption Model, the ... paper, improve patient engagement and automate processes. The ... transitioned from paper-driven to electronic workflows, patient registration ... hard copies of consents. With HIMSS Stage 7 ...
(Date:5/6/2015)... Experienced Vancouver air conditioning installation and repair company, ... now conduct their cooling services, including air conditioning repair ... and residential units. Strata complex air conditioning services are ... knowledge as well as a professionally trained staff. ... away any old air conditioning unit to be recycled, ...
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... colon hydrotherapy supplier, is excited to announce a ... will help reduce the industry’s carbon footprint while ... These kits feature Eco-Flex™, the world’s ... “This is a game-changer for hydrotherapists,” claims the ...
(Date:5/6/2015)... May 06, 2015 Animals make just as ... are also good for your health. An Ohio veterinarian ... an increase he's seeing with health advantages of owning a ... When it comes to pet ownership, there are proven health ... Dr. Scott Leffler of the Animal Medical Center ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Inversion ... specializes in yoga and Pilates classes, provides personalized ... and products, starting with its new Pilates Ring ... effort of becoming leaner, stronger, more centered and ... offer a fresh venue to healthy fitness through ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3
... renowned health,professionals are joining forces at the 2nd ... Conference, April 3-6, 2008 in,Taos, New Mexico. Research ... today,s most pertinent health issues including celiac disease, ... Based on extensive medical research, IHI has ...
... Mesa Laboratories,Inc. (Nasdaq: MLAB ) today reported significantly ... nine months ended December 31, 2007., Highlights:, ... net income increases 37% -- Third quarter diluted EPS ... net sales increased 13 percent to,$4,614,000 from $4,095,000 in the ...
... Unlike other epilepsy meds, Trileptal was no better than ... -- The epilepsy drug oxcarbazepine (Trileptal) does not seem ... finds. , Migraines affect more than 28 million Americans, ... effective in preventing these severe headaches. For this reason, ...
... among men not as low as should be , , MONDAY, ... the increase among American women, and the prevalence of this ... men is still not as low as it should be, ... than optimal is among the leading two or three risks ...
... Presented at Annual Meeting of the American Academy of ... ... NeoStrata today released new,clinical data that demonstrates significant benefits in ... at-home products in improving the appearance,and texture of facial skin. The ...
... February 11, 2008 Wiley-Blackwell, the scientific, technical, ... & Sons, Inc. (NYSE: JWa), (NYSE: JWb), today ... named the 2007 Best New Journal-Social Sciences & ... & Scholarly Publishing (PSP) Division. Each year, the ...
Cached Medicine News:Health News:Conference to Explore America's Health Challenges 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 4Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 5Health News:Epilepsy Drug Doesn't Prevent Migraines 2Health News:High Blood Pressure on Increase Among American Women 2Health News:NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin 2Health News:Mind, Brain, and Education is recognized as best new journal 2
Provides rigid support and immobilization for the knee...
The Bledsoe Ultimate CI is a sport functional knee brace designed for instabilities of combined ACL and PCL injured knees. Additional knee injuries to the medial collateral ligament along with the cr...
... The Bledsoe Revolution ... for speed fitting under ... frees the surgeon or ... time-consuming post-op fitting and ...
The Bledsoe Basic Knee Brace offers a broad range of features that are unmatched by any other brace in its price range. Application of this brace is the easiest of any brace on the market....
Medicine Products: